$RXSF Executive & Investor Summaries, $150m Revs/$43m EBITDA Projected over 3 Years >> http://www.rxdrugsafe.com/files/Executive%20Summary_RX%20Safes_December%202015.compressed.pdf http://www.rxdrugsafe.com/files/Rx%20Safes%20Presentation%20December%202015_Website%20Version.compressed.pdf